© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

SRI

Top section

Top section

Adnoc expands sustainable financing with $2bn green loan

The company's new loan is backed by a Korean export credit agency
By backing too many speculative IPOs, investment banks could threaten the whole market
SSA

IDB Invest becomes first MDB to tap its securitization

$450m add-on makes deal more efficient

Finland's YIT signs €200m SLL and amends term loan

Company retains same roster of banks that provided last loan
By backing too many speculative IPOs, investment banks could threaten the whole market
Sub-sections
  • Organon, the spin-off from US pharma company Merck, has launched a bond leg of its financing, which will establish the unit as a separate firm with its own capital structure, while funding a $9bn dividend to its former parent. The firm was initially offering $4.5bn-equivalent across secured and unsecured bonds, with a bias to the deeper dollar market, but scaled this up during syndication to allow it to strip out bank debt.
  • We Doctor Holdings, which operates Chinese healthcare platform WeDoctor, is seeking approval for a Hong Kong IPO.
  • Synlab, the German laboratory diagnostic services company, has announced its intention to float on the Frankfurt Stock Exchange.